Stock screenerAll disclosures →
EDGAR →
RGNX
Conviction 36HealthcareScan · Mon, Aug 10, 2026RGNX$10.43-2.71%
ResistanceSupportVol 14Insider sellVol MA14 1.32M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price10.43
Change-2.71%
Gap-0.79%
Rel volume1.41×
Avg volume1.75M
Avg $ vol18.2M
SMA 2010.42
SMA 509.95
SMA 20010.52
Price vs 50+4.87%
Price vs 200-0.82%
MA stackmixed
50/200 cross—
Supertrenddown · 12.27
RSI (14)49
MACD hist-0.01
MACD cross—
Stoch %K / %D54 / 70
ADX (14)20
+DI / −DI25 / 25
RSI divergence—
MACD divergence—
ATR %+8.31%
ADR %7.21%
52w high15.98
52w low5.65
From 52w high-34.73%
Above 52w low+84.60%
New 52w highNo
SqueezeOff
Bollinger width29.58%
%B0.50
Donchian pos43.89%
Donchian high13.00
Donchian low8.42
AVWAP (52w high)9.49
vs AVWAP high+9.92%
AVWAP (52w low)9.78
vs AVWAP low+6.61%
OBV trendDown
Chaikin MF (20)0.09
Today vs 20d1.41×
Avg vol (14d)1.32M
Avg vol (20d)1.75M
Avg $ vol (20d)18.2M
Market cap688.52M
RS 3m (vs SPY)-2.82%
RS 6m (vs SPY)-9.63%
RS line new highNo
Trend template2/8
Technical rank40.0
1 week+4.72%
1 month-25.23%
3 months-1.14%
6 months+0.97%
1 year+32.03%
YTD-23.14%
P/E-3.55
P/B9.59
P/S4.04
P/FCF-5.45
EPS-3.76
Div yield—
ROE-270.16%
ROA-50.15%
Debt/Eq—
Current2.86
EV/EBITDA-4.48
Gross margin—
Net margin-113.75%
Rev growth104.54%
EPS growth14.63%
Price target23.30
Target upside123.39%
Analyst ratingBuy
Institutional70.03%
Ent. value652.03M
Revenue108.02M
Net income22.71M
Gross profit—
Free cash flow-126.38M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out51.7M
Employees371
ListedThu, Sep 17, 2015
Free float38.66M
Float %74.9%
Short interest8.63M
Days to cover3.3d
Short volume43.1%
Squeeze score65 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.43 vs $0.12
Last surprise+258.3% beat
Setup gradeD
Conviction36 / 100
Pattern quality—
Tech rank40.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance13.69
Support8.80
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RGNX
No recent disclosed trades by Congress in RGNX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RGNX · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bennett Jean Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Glucksmann Alexandra Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Tasse Daniel Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
Zachary Jennifer Director · Common Stock · 2026-05-29 | Grant | 9.81K | $0 | 2026-05-29 | 2026-06-02 |
Fox Allan M. Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
KARABELAS ARGERIS N Director · Stock Options (Right to Buy) · 2026-05-29 | Grant | 46.6K | $0 | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in RGNX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.